Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $7.4 million.

  • CG Oncology's Interest & Investment Income fell 5.97% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 23.94%. This contributed to the annual value of $26.6 million for FY2024, which is 285.63% up from last year.
  • Per CG Oncology's latest filing, its Interest & Investment Income stood at $7.4 million for Q3 2025, which was up 1.39% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Interest & Investment Income ranged from a high of $7.9 million in Q3 2024 and a low of $771,000 during Q2 2023.
  • Over the past 3 years, CG Oncology's median Interest & Investment Income value was $6.2 million (recorded in 2024), while the average stood at $5.1 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 800.52% in 2024, then fell by 5.97% in 2025.
  • Over the past 3 years, CG Oncology's Interest & Investment Income (Quarterly) stood at $2.8 million in 2023, then skyrocketed by 122.72% to $6.2 million in 2024, then decreased by 5.97% to $7.4 million in 2025.
  • Its Interest & Investment Income stands at $7.4 million for Q3 2025, versus $7.3 million for Q2 2025 and $7.7 million for Q1 2025.